nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocortisone—ABCG2—Sorafenib—liver cancer	0.117	0.196	CbGbCtD
Hydrocortisone—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0863	0.145	CbGbCtD
Hydrocortisone—CYP3A7—Sorafenib—liver cancer	0.0863	0.145	CbGbCtD
Hydrocortisone—ABCG2—Doxorubicin—liver cancer	0.0709	0.119	CbGbCtD
Hydrocortisone—CYP3A5—Sorafenib—liver cancer	0.0647	0.109	CbGbCtD
Hydrocortisone—CYP2C8—Sorafenib—liver cancer	0.0622	0.105	CbGbCtD
Hydrocortisone—ABCB1—Sorafenib—liver cancer	0.0421	0.0707	CbGbCtD
Hydrocortisone—ABCB1—Doxorubicin—liver cancer	0.0255	0.0429	CbGbCtD
Hydrocortisone—CYP3A4—Sorafenib—liver cancer	0.0252	0.0424	CbGbCtD
Hydrocortisone—CYP3A4—Doxorubicin—liver cancer	0.0153	0.0257	CbGbCtD
Hydrocortisone—Redness—Epirubicin—liver cancer	0.00103	0.00508	CcSEcCtD
Hydrocortisone—Folliculitis—Doxorubicin—liver cancer	0.00102	0.00504	CcSEcCtD
Hydrocortisone—Embolism—Doxorubicin—liver cancer	0.000999	0.00494	CcSEcCtD
Hydrocortisone—Hepatomegaly—Epirubicin—liver cancer	0.000979	0.00484	CcSEcCtD
Hydrocortisone—Redness—Doxorubicin—liver cancer	0.00095	0.0047	CcSEcCtD
Hydrocortisone—Haemoglobin—Sorafenib—liver cancer	0.000947	0.00468	CcSEcCtD
Hydrocortisone—Haemorrhage—Sorafenib—liver cancer	0.000942	0.00466	CcSEcCtD
Hydrocortisone—Neuritis—Epirubicin—liver cancer	0.000928	0.00459	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Sorafenib—liver cancer	0.000925	0.00458	CcSEcCtD
Hydrocortisone—Hepatomegaly—Doxorubicin—liver cancer	0.000906	0.00448	CcSEcCtD
Hydrocortisone—Fungal infection—Epirubicin—liver cancer	0.000898	0.00444	CcSEcCtD
Hydrocortisone—Necrosis—Epirubicin—liver cancer	0.000883	0.00437	CcSEcCtD
Hydrocortisone—Abscess—Epirubicin—liver cancer	0.000876	0.00433	CcSEcCtD
Hydrocortisone—Neuritis—Doxorubicin—liver cancer	0.000859	0.00425	CcSEcCtD
Hydrocortisone—Stinging—Epirubicin—liver cancer	0.000856	0.00423	CcSEcCtD
Hydrocortisone—Glycosuria—Epirubicin—liver cancer	0.000856	0.00423	CcSEcCtD
Hydrocortisone—Immune system disorder—Sorafenib—liver cancer	0.000851	0.00421	CcSEcCtD
Hydrocortisone—Petechiae—Epirubicin—liver cancer	0.000842	0.00417	CcSEcCtD
Hydrocortisone—Arrhythmia—Sorafenib—liver cancer	0.000841	0.00416	CcSEcCtD
Hydrocortisone—Fungal infection—Doxorubicin—liver cancer	0.000831	0.00411	CcSEcCtD
Hydrocortisone—Mental disorder—Sorafenib—liver cancer	0.000825	0.00408	CcSEcCtD
Hydrocortisone—Malnutrition—Sorafenib—liver cancer	0.00082	0.00405	CcSEcCtD
Hydrocortisone—Erythema—Sorafenib—liver cancer	0.00082	0.00405	CcSEcCtD
Hydrocortisone—Necrosis—Doxorubicin—liver cancer	0.000817	0.00404	CcSEcCtD
Hydrocortisone—Abscess—Doxorubicin—liver cancer	0.000811	0.00401	CcSEcCtD
Hydrocortisone—Glycosuria—Doxorubicin—liver cancer	0.000792	0.00391	CcSEcCtD
Hydrocortisone—Stinging—Doxorubicin—liver cancer	0.000792	0.00391	CcSEcCtD
Hydrocortisone—Amenorrhoea—Epirubicin—liver cancer	0.000789	0.0039	CcSEcCtD
Hydrocortisone—Petechiae—Doxorubicin—liver cancer	0.00078	0.00385	CcSEcCtD
Hydrocortisone—Skin discolouration—Epirubicin—liver cancer	0.000767	0.00379	CcSEcCtD
Hydrocortisone—Viral infection—Epirubicin—liver cancer	0.000767	0.00379	CcSEcCtD
Hydrocortisone—Rectal haemorrhage—Epirubicin—liver cancer	0.000767	0.00379	CcSEcCtD
Hydrocortisone—Arthropathy—Epirubicin—liver cancer	0.000762	0.00377	CcSEcCtD
Hydrocortisone—Angioedema—Sorafenib—liver cancer	0.000749	0.0037	CcSEcCtD
Hydrocortisone—Syncope—Sorafenib—liver cancer	0.000735	0.00364	CcSEcCtD
Hydrocortisone—Amenorrhoea—Doxorubicin—liver cancer	0.00073	0.00361	CcSEcCtD
Hydrocortisone—Loss of consciousness—Sorafenib—liver cancer	0.000721	0.00356	CcSEcCtD
Hydrocortisone—Inflammation—Epirubicin—liver cancer	0.000715	0.00353	CcSEcCtD
Hydrocortisone—Skin discolouration—Doxorubicin—liver cancer	0.00071	0.00351	CcSEcCtD
Hydrocortisone—Viral infection—Doxorubicin—liver cancer	0.00071	0.00351	CcSEcCtD
Hydrocortisone—Rectal haemorrhage—Doxorubicin—liver cancer	0.00071	0.00351	CcSEcCtD
Hydrocortisone—Hypertension—Sorafenib—liver cancer	0.000708	0.0035	CcSEcCtD
Hydrocortisone—Arthropathy—Doxorubicin—liver cancer	0.000705	0.00349	CcSEcCtD
Hydrocortisone—Myalgia—Sorafenib—liver cancer	0.000698	0.00345	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000693	0.00343	CcSEcCtD
Hydrocortisone—Hiccups—Epirubicin—liver cancer	0.000693	0.00343	CcSEcCtD
Hydrocortisone—Dermatitis contact—Epirubicin—liver cancer	0.000685	0.00339	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Sorafenib—liver cancer	0.000669	0.00331	CcSEcCtD
Hydrocortisone—Infection—Sorafenib—liver cancer	0.000665	0.00329	CcSEcCtD
Hydrocortisone—Skin exfoliation—Epirubicin—liver cancer	0.000662	0.00327	CcSEcCtD
Hydrocortisone—Inflammation—Doxorubicin—liver cancer	0.000661	0.00327	CcSEcCtD
Hydrocortisone—Shock—Sorafenib—liver cancer	0.000658	0.00325	CcSEcCtD
Hydrocortisone—Fluid retention—Epirubicin—liver cancer	0.000658	0.00325	CcSEcCtD
Hydrocortisone—Nervous system disorder—Sorafenib—liver cancer	0.000656	0.00324	CcSEcCtD
Hydrocortisone—Neuropathy—Epirubicin—liver cancer	0.000651	0.00322	CcSEcCtD
Hydrocortisone—Skin disorder—Sorafenib—liver cancer	0.00065	0.00321	CcSEcCtD
Hydrocortisone—Hiccups—Doxorubicin—liver cancer	0.000641	0.00317	CcSEcCtD
Hydrocortisone—Dry eye—Epirubicin—liver cancer	0.00064	0.00317	CcSEcCtD
Hydrocortisone—Anorexia—Sorafenib—liver cancer	0.000638	0.00315	CcSEcCtD
Hydrocortisone—Dermatitis contact—Doxorubicin—liver cancer	0.000634	0.00313	CcSEcCtD
Hydrocortisone—Oesophagitis—Epirubicin—liver cancer	0.000633	0.00313	CcSEcCtD
Hydrocortisone—Rash maculo-papular—Epirubicin—liver cancer	0.00063	0.00311	CcSEcCtD
Hydrocortisone—Ecchymosis—Epirubicin—liver cancer	0.000627	0.0031	CcSEcCtD
Hydrocortisone—Pulmonary oedema—Epirubicin—liver cancer	0.000617	0.00305	CcSEcCtD
Hydrocortisone—Skin exfoliation—Doxorubicin—liver cancer	0.000612	0.00303	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00061	0.00301	CcSEcCtD
Hydrocortisone—Fluid retention—Doxorubicin—liver cancer	0.000609	0.00301	CcSEcCtD
Hydrocortisone—Neuropathy—Doxorubicin—liver cancer	0.000602	0.00298	CcSEcCtD
Hydrocortisone—Dry eye—Doxorubicin—liver cancer	0.000592	0.00293	CcSEcCtD
Hydrocortisone—Dyspepsia—Sorafenib—liver cancer	0.000589	0.00291	CcSEcCtD
Hydrocortisone—Oesophagitis—Doxorubicin—liver cancer	0.000586	0.0029	CcSEcCtD
Hydrocortisone—Rash maculo-papular—Doxorubicin—liver cancer	0.000583	0.00288	CcSEcCtD
Hydrocortisone—Decreased appetite—Sorafenib—liver cancer	0.000582	0.00288	CcSEcCtD
Hydrocortisone—Thrombophlebitis—Epirubicin—liver cancer	0.000581	0.00287	CcSEcCtD
Hydrocortisone—Ecchymosis—Doxorubicin—liver cancer	0.00058	0.00287	CcSEcCtD
Hydrocortisone—Diabetes mellitus—Epirubicin—liver cancer	0.000578	0.00286	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Sorafenib—liver cancer	0.000578	0.00286	CcSEcCtD
Hydrocortisone—Fatigue—Sorafenib—liver cancer	0.000577	0.00285	CcSEcCtD
Hydrocortisone—Pain—Sorafenib—liver cancer	0.000572	0.00283	CcSEcCtD
Hydrocortisone—Pulmonary oedema—Doxorubicin—liver cancer	0.000571	0.00282	CcSEcCtD
Hydrocortisone—Eczema—Epirubicin—liver cancer	0.00056	0.00277	CcSEcCtD
Hydrocortisone—Cardiac failure congestive—Epirubicin—liver cancer	0.000555	0.00274	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Sorafenib—liver cancer	0.000547	0.00271	CcSEcCtD
Hydrocortisone—Levonorgestrel—ESR1—liver cancer	0.000544	0.146	CrCbGaD
Hydrocortisone—Thrombophlebitis—Doxorubicin—liver cancer	0.000538	0.00266	CcSEcCtD
Hydrocortisone—Increased appetite—Epirubicin—liver cancer	0.000536	0.00265	CcSEcCtD
Hydrocortisone—Diabetes mellitus—Doxorubicin—liver cancer	0.000535	0.00265	CcSEcCtD
Hydrocortisone—Urticaria—Sorafenib—liver cancer	0.000532	0.00263	CcSEcCtD
Hydrocortisone—Abdominal pain—Sorafenib—liver cancer	0.000529	0.00262	CcSEcCtD
Hydrocortisone—Body temperature increased—Sorafenib—liver cancer	0.000529	0.00262	CcSEcCtD
Hydrocortisone—Anaphylactoid reaction—Epirubicin—liver cancer	0.00052	0.00257	CcSEcCtD
Hydrocortisone—Fluoxymesterone—ESR1—liver cancer	0.000519	0.139	CrCbGaD
Hydrocortisone—Eczema—Doxorubicin—liver cancer	0.000518	0.00256	CcSEcCtD
Hydrocortisone—Cardiac failure—Epirubicin—liver cancer	0.000516	0.00255	CcSEcCtD
Hydrocortisone—Lethargy—Epirubicin—liver cancer	0.000513	0.00254	CcSEcCtD
Hydrocortisone—Cardiac failure congestive—Doxorubicin—liver cancer	0.000513	0.00254	CcSEcCtD
Hydrocortisone—Osteoarthritis—Epirubicin—liver cancer	0.000503	0.00249	CcSEcCtD
Hydrocortisone—Danazol—ESR1—liver cancer	0.000496	0.133	CrCbGaD
Hydrocortisone—Increased appetite—Doxorubicin—liver cancer	0.000495	0.00245	CcSEcCtD
Hydrocortisone—Affect lability—Epirubicin—liver cancer	0.000495	0.00245	CcSEcCtD
Hydrocortisone—Hypersensitivity—Sorafenib—liver cancer	0.000493	0.00244	CcSEcCtD
Hydrocortisone—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000481	0.00238	CcSEcCtD
Hydrocortisone—Asthenia—Sorafenib—liver cancer	0.00048	0.00237	CcSEcCtD
Hydrocortisone—Cardiac arrest—Epirubicin—liver cancer	0.000478	0.00237	CcSEcCtD
Hydrocortisone—Cardiac failure—Doxorubicin—liver cancer	0.000477	0.00236	CcSEcCtD
Hydrocortisone—Mood swings—Epirubicin—liver cancer	0.000477	0.00236	CcSEcCtD
Hydrocortisone—Lethargy—Doxorubicin—liver cancer	0.000475	0.00235	CcSEcCtD
Hydrocortisone—Pruritus—Sorafenib—liver cancer	0.000473	0.00234	CcSEcCtD
Hydrocortisone—Osteoarthritis—Doxorubicin—liver cancer	0.000466	0.0023	CcSEcCtD
Hydrocortisone—Dry skin—Epirubicin—liver cancer	0.000461	0.00228	CcSEcCtD
Hydrocortisone—Abdominal pain upper—Epirubicin—liver cancer	0.00046	0.00227	CcSEcCtD
Hydrocortisone—Affect lability—Doxorubicin—liver cancer	0.000458	0.00227	CcSEcCtD
Hydrocortisone—Hypokalaemia—Epirubicin—liver cancer	0.000458	0.00226	CcSEcCtD
Hydrocortisone—Diarrhoea—Sorafenib—liver cancer	0.000458	0.00226	CcSEcCtD
Hydrocortisone—Medroxyprogesterone Acetate—ESR1—liver cancer	0.000445	0.119	CrCbGaD
Hydrocortisone—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000444	0.00219	CcSEcCtD
Hydrocortisone—Muscular weakness—Epirubicin—liver cancer	0.000444	0.00219	CcSEcCtD
Hydrocortisone—Cardiac arrest—Doxorubicin—liver cancer	0.000443	0.00219	CcSEcCtD
Hydrocortisone—Dizziness—Sorafenib—liver cancer	0.000442	0.00219	CcSEcCtD
Hydrocortisone—Mood swings—Doxorubicin—liver cancer	0.000441	0.00218	CcSEcCtD
Hydrocortisone—Abdominal distension—Epirubicin—liver cancer	0.000438	0.00216	CcSEcCtD
Hydrocortisone—Dry skin—Doxorubicin—liver cancer	0.000427	0.00211	CcSEcCtD
Hydrocortisone—Pancreatitis—Epirubicin—liver cancer	0.000426	0.00211	CcSEcCtD
Hydrocortisone—Vomiting—Sorafenib—liver cancer	0.000425	0.0021	CcSEcCtD
Hydrocortisone—Abdominal pain upper—Doxorubicin—liver cancer	0.000425	0.0021	CcSEcCtD
Hydrocortisone—Hypokalaemia—Doxorubicin—liver cancer	0.000424	0.00209	CcSEcCtD
Hydrocortisone—Rash—Sorafenib—liver cancer	0.000422	0.00209	CcSEcCtD
Hydrocortisone—Dermatitis—Sorafenib—liver cancer	0.000421	0.00208	CcSEcCtD
Hydrocortisone—Headache—Sorafenib—liver cancer	0.000419	0.00207	CcSEcCtD
Hydrocortisone—Muscular weakness—Doxorubicin—liver cancer	0.000411	0.00203	CcSEcCtD
Hydrocortisone—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000411	0.00203	CcSEcCtD
Hydrocortisone—Abdominal distension—Doxorubicin—liver cancer	0.000405	0.002	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Epirubicin—liver cancer	0.000404	0.002	CcSEcCtD
Hydrocortisone—Nausea—Sorafenib—liver cancer	0.000397	0.00197	CcSEcCtD
Hydrocortisone—Weight increased—Epirubicin—liver cancer	0.000396	0.00196	CcSEcCtD
Hydrocortisone—Pancreatitis—Doxorubicin—liver cancer	0.000394	0.00195	CcSEcCtD
Hydrocortisone—Weight decreased—Epirubicin—liver cancer	0.000393	0.00195	CcSEcCtD
Hydrocortisone—Infestation NOS—Epirubicin—liver cancer	0.000388	0.00192	CcSEcCtD
Hydrocortisone—Infestation—Epirubicin—liver cancer	0.000388	0.00192	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Epirubicin—liver cancer	0.00038	0.00188	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000374	0.00185	CcSEcCtD
Hydrocortisone—Weight increased—Doxorubicin—liver cancer	0.000366	0.00181	CcSEcCtD
Hydrocortisone—Weight decreased—Doxorubicin—liver cancer	0.000364	0.0018	CcSEcCtD
Hydrocortisone—Infestation—Doxorubicin—liver cancer	0.000359	0.00177	CcSEcCtD
Hydrocortisone—Infestation NOS—Doxorubicin—liver cancer	0.000359	0.00177	CcSEcCtD
Hydrocortisone—Bradycardia—Epirubicin—liver cancer	0.000354	0.00175	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Doxorubicin—liver cancer	0.000352	0.00174	CcSEcCtD
Hydrocortisone—Haemoglobin—Epirubicin—liver cancer	0.00035	0.00173	CcSEcCtD
Hydrocortisone—Haemorrhage—Epirubicin—liver cancer	0.000348	0.00172	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Epirubicin—liver cancer	0.000342	0.00169	CcSEcCtD
Hydrocortisone—Bradycardia—Doxorubicin—liver cancer	0.000328	0.00162	CcSEcCtD
Hydrocortisone—Eye disorder—Epirubicin—liver cancer	0.000325	0.00161	CcSEcCtD
Hydrocortisone—Haemoglobin—Doxorubicin—liver cancer	0.000324	0.0016	CcSEcCtD
Hydrocortisone—Haemorrhage—Doxorubicin—liver cancer	0.000322	0.00159	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Doxorubicin—liver cancer	0.000316	0.00156	CcSEcCtD
Hydrocortisone—Immune system disorder—Epirubicin—liver cancer	0.000314	0.00155	CcSEcCtD
Hydrocortisone—Arrhythmia—Epirubicin—liver cancer	0.000311	0.00154	CcSEcCtD
Hydrocortisone—Mental disorder—Epirubicin—liver cancer	0.000305	0.00151	CcSEcCtD
Hydrocortisone—Malnutrition—Epirubicin—liver cancer	0.000303	0.0015	CcSEcCtD
Hydrocortisone—Erythema—Epirubicin—liver cancer	0.000303	0.0015	CcSEcCtD
Hydrocortisone—Eye disorder—Doxorubicin—liver cancer	0.000301	0.00149	CcSEcCtD
Hydrocortisone—Immune system disorder—Doxorubicin—liver cancer	0.000291	0.00144	CcSEcCtD
Hydrocortisone—Arrhythmia—Doxorubicin—liver cancer	0.000288	0.00142	CcSEcCtD
Hydrocortisone—Mental disorder—Doxorubicin—liver cancer	0.000282	0.00139	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Epirubicin—liver cancer	0.000281	0.00139	CcSEcCtD
Hydrocortisone—Erythema—Doxorubicin—liver cancer	0.00028	0.00139	CcSEcCtD
Hydrocortisone—Malnutrition—Doxorubicin—liver cancer	0.00028	0.00139	CcSEcCtD
Hydrocortisone—Malaise—Epirubicin—liver cancer	0.000273	0.00135	CcSEcCtD
Hydrocortisone—Vertigo—Epirubicin—liver cancer	0.000272	0.00135	CcSEcCtD
Hydrocortisone—Syncope—Epirubicin—liver cancer	0.000272	0.00134	CcSEcCtD
Hydrocortisone—Loss of consciousness—Epirubicin—liver cancer	0.000266	0.00132	CcSEcCtD
Hydrocortisone—Convulsion—Epirubicin—liver cancer	0.000263	0.0013	CcSEcCtD
Hydrocortisone—Hypertension—Epirubicin—liver cancer	0.000262	0.00129	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Doxorubicin—liver cancer	0.00026	0.00129	CcSEcCtD
Hydrocortisone—Myalgia—Epirubicin—liver cancer	0.000258	0.00128	CcSEcCtD
Hydrocortisone—Anxiety—Epirubicin—liver cancer	0.000257	0.00127	CcSEcCtD
Hydrocortisone—Progesterone—ESR1—liver cancer	0.000257	0.0689	CrCbGaD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000256	0.00127	CcSEcCtD
Hydrocortisone—Discomfort—Epirubicin—liver cancer	0.000255	0.00126	CcSEcCtD
Hydrocortisone—Malaise—Doxorubicin—liver cancer	0.000253	0.00125	CcSEcCtD
Hydrocortisone—Vertigo—Doxorubicin—liver cancer	0.000252	0.00125	CcSEcCtD
Hydrocortisone—Syncope—Doxorubicin—liver cancer	0.000251	0.00124	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Epirubicin—liver cancer	0.000247	0.00122	CcSEcCtD
Hydrocortisone—Oedema—Epirubicin—liver cancer	0.000247	0.00122	CcSEcCtD
Hydrocortisone—Loss of consciousness—Doxorubicin—liver cancer	0.000246	0.00122	CcSEcCtD
Hydrocortisone—Infection—Epirubicin—liver cancer	0.000246	0.00121	CcSEcCtD
Hydrocortisone—Shock—Epirubicin—liver cancer	0.000243	0.0012	CcSEcCtD
Hydrocortisone—Convulsion—Doxorubicin—liver cancer	0.000243	0.0012	CcSEcCtD
Hydrocortisone—Nervous system disorder—Epirubicin—liver cancer	0.000243	0.0012	CcSEcCtD
Hydrocortisone—Hypertension—Doxorubicin—liver cancer	0.000242	0.0012	CcSEcCtD
Hydrocortisone—Tachycardia—Epirubicin—liver cancer	0.000241	0.00119	CcSEcCtD
Hydrocortisone—Skin disorder—Epirubicin—liver cancer	0.00024	0.00119	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Epirubicin—liver cancer	0.000239	0.00118	CcSEcCtD
Hydrocortisone—Myalgia—Doxorubicin—liver cancer	0.000239	0.00118	CcSEcCtD
Hydrocortisone—Anxiety—Doxorubicin—liver cancer	0.000238	0.00118	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000237	0.00117	CcSEcCtD
Hydrocortisone—Discomfort—Doxorubicin—liver cancer	0.000236	0.00117	CcSEcCtD
Hydrocortisone—Anorexia—Epirubicin—liver cancer	0.000236	0.00117	CcSEcCtD
Hydrocortisone—Hypotension—Epirubicin—liver cancer	0.000231	0.00114	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Doxorubicin—liver cancer	0.000229	0.00113	CcSEcCtD
Hydrocortisone—Oedema—Doxorubicin—liver cancer	0.000229	0.00113	CcSEcCtD
Hydrocortisone—Infection—Doxorubicin—liver cancer	0.000227	0.00112	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000225	0.00111	CcSEcCtD
Hydrocortisone—Shock—Doxorubicin—liver cancer	0.000225	0.00111	CcSEcCtD
Hydrocortisone—Nervous system disorder—Doxorubicin—liver cancer	0.000224	0.00111	CcSEcCtD
Hydrocortisone—Insomnia—Epirubicin—liver cancer	0.000224	0.00111	CcSEcCtD
Hydrocortisone—Tachycardia—Doxorubicin—liver cancer	0.000223	0.0011	CcSEcCtD
Hydrocortisone—Skin disorder—Doxorubicin—liver cancer	0.000222	0.0011	CcSEcCtD
Hydrocortisone—Paraesthesia—Epirubicin—liver cancer	0.000222	0.0011	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Doxorubicin—liver cancer	0.000221	0.00109	CcSEcCtD
Hydrocortisone—Anorexia—Doxorubicin—liver cancer	0.000218	0.00108	CcSEcCtD
Hydrocortisone—Dyspepsia—Epirubicin—liver cancer	0.000218	0.00108	CcSEcCtD
Hydrocortisone—Decreased appetite—Epirubicin—liver cancer	0.000215	0.00106	CcSEcCtD
Hydrocortisone—Hypotension—Doxorubicin—liver cancer	0.000214	0.00106	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Epirubicin—liver cancer	0.000213	0.00106	CcSEcCtD
Hydrocortisone—Fatigue—Epirubicin—liver cancer	0.000213	0.00105	CcSEcCtD
Hydrocortisone—Pain—Epirubicin—liver cancer	0.000211	0.00105	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000208	0.00103	CcSEcCtD
Hydrocortisone—Insomnia—Doxorubicin—liver cancer	0.000207	0.00102	CcSEcCtD
Hydrocortisone—Progesterone—CYP1A1—liver cancer	0.000205	0.0551	CrCbGaD
Hydrocortisone—Paraesthesia—Doxorubicin—liver cancer	0.000205	0.00102	CcSEcCtD
Hydrocortisone—Feeling abnormal—Epirubicin—liver cancer	0.000204	0.00101	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Epirubicin—liver cancer	0.000202	0.001	CcSEcCtD
Hydrocortisone—Dyspepsia—Doxorubicin—liver cancer	0.000201	0.000996	CcSEcCtD
Hydrocortisone—Prednisone—ALB—liver cancer	0.000199	0.0534	CrCbGaD
Hydrocortisone—Decreased appetite—Doxorubicin—liver cancer	0.000199	0.000983	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000198	0.000977	CcSEcCtD
Hydrocortisone—Fatigue—Doxorubicin—liver cancer	0.000197	0.000975	CcSEcCtD
Hydrocortisone—Urticaria—Epirubicin—liver cancer	0.000196	0.000971	CcSEcCtD
Hydrocortisone—Norethindrone—ALB—liver cancer	0.000196	0.0526	CrCbGaD
Hydrocortisone—Pain—Doxorubicin—liver cancer	0.000196	0.000967	CcSEcCtD
Hydrocortisone—Abdominal pain—Epirubicin—liver cancer	0.000195	0.000966	CcSEcCtD
Hydrocortisone—Body temperature increased—Epirubicin—liver cancer	0.000195	0.000966	CcSEcCtD
Hydrocortisone—Testosterone—CYP1A1—liver cancer	0.000194	0.0521	CrCbGaD
Hydrocortisone—Dexamethasone—CYP2E1—liver cancer	0.00019	0.0511	CrCbGaD
Hydrocortisone—Feeling abnormal—Doxorubicin—liver cancer	0.000189	0.000932	CcSEcCtD
Hydrocortisone—Dexamethasone—CYP1A1—liver cancer	0.000188	0.0504	CrCbGaD
Hydrocortisone—Gastrointestinal pain—Doxorubicin—liver cancer	0.000187	0.000925	CcSEcCtD
Hydrocortisone—Methyltestosterone—ALB—liver cancer	0.000186	0.05	CrCbGaD
Hydrocortisone—Hypersensitivity—Epirubicin—liver cancer	0.000182	0.000901	CcSEcCtD
Hydrocortisone—Urticaria—Doxorubicin—liver cancer	0.000182	0.000899	CcSEcCtD
Hydrocortisone—Body temperature increased—Doxorubicin—liver cancer	0.000181	0.000894	CcSEcCtD
Hydrocortisone—Abdominal pain—Doxorubicin—liver cancer	0.000181	0.000894	CcSEcCtD
Hydrocortisone—Asthenia—Epirubicin—liver cancer	0.000177	0.000877	CcSEcCtD
Hydrocortisone—Pruritus—Epirubicin—liver cancer	0.000175	0.000865	CcSEcCtD
Hydrocortisone—Diarrhoea—Epirubicin—liver cancer	0.000169	0.000837	CcSEcCtD
Hydrocortisone—Hypersensitivity—Doxorubicin—liver cancer	0.000169	0.000833	CcSEcCtD
Hydrocortisone—Asthenia—Doxorubicin—liver cancer	0.000164	0.000812	CcSEcCtD
Hydrocortisone—Dizziness—Epirubicin—liver cancer	0.000164	0.000808	CcSEcCtD
Hydrocortisone—Pruritus—Doxorubicin—liver cancer	0.000162	0.0008	CcSEcCtD
Hydrocortisone—Vomiting—Epirubicin—liver cancer	0.000157	0.000777	CcSEcCtD
Hydrocortisone—Diarrhoea—Doxorubicin—liver cancer	0.000157	0.000774	CcSEcCtD
Hydrocortisone—Rash—Epirubicin—liver cancer	0.000156	0.000771	CcSEcCtD
Hydrocortisone—Dermatitis—Epirubicin—liver cancer	0.000156	0.00077	CcSEcCtD
Hydrocortisone—Headache—Epirubicin—liver cancer	0.000155	0.000766	CcSEcCtD
Hydrocortisone—Dizziness—Doxorubicin—liver cancer	0.000151	0.000748	CcSEcCtD
Hydrocortisone—Nausea—Epirubicin—liver cancer	0.000147	0.000726	CcSEcCtD
Hydrocortisone—Vomiting—Doxorubicin—liver cancer	0.000145	0.000719	CcSEcCtD
Hydrocortisone—Rash—Doxorubicin—liver cancer	0.000144	0.000713	CcSEcCtD
Hydrocortisone—Dermatitis—Doxorubicin—liver cancer	0.000144	0.000713	CcSEcCtD
Hydrocortisone—Headache—Doxorubicin—liver cancer	0.000143	0.000709	CcSEcCtD
Hydrocortisone—Nausea—Doxorubicin—liver cancer	0.000136	0.000672	CcSEcCtD
Hydrocortisone—Testosterone—ALB—liver cancer	0.000108	0.029	CrCbGaD
Hydrocortisone—SLCO1A2—Metabolism—GOT1—liver cancer	3.24e-05	0.000163	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PIK3CD—liver cancer	3.23e-05	0.000162	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	3.22e-05	0.000162	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GSTA2—liver cancer	3.22e-05	0.000162	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PIK3CB—liver cancer	3.2e-05	0.000161	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MTOR—liver cancer	3.2e-05	0.000161	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—ALB—liver cancer	3.19e-05	0.00016	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—NR1H4—liver cancer	3.18e-05	0.00016	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PIK3CG—liver cancer	3.16e-05	0.000159	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	3.13e-05	0.000158	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	3.13e-05	0.000157	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GSTA3—liver cancer	3.13e-05	0.000157	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GSTA1—liver cancer	3.1e-05	0.000156	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	3.1e-05	0.000156	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—NAT2—liver cancer	3.07e-05	0.000154	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—HRAS—liver cancer	3.06e-05	0.000154	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PPARG—liver cancer	3.05e-05	0.000154	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PSMD10—liver cancer	3.05e-05	0.000153	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PSMA4—liver cancer	3.05e-05	0.000153	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	3.03e-05	0.000152	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PSMD10—liver cancer	3.02e-05	0.000152	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PSMA4—liver cancer	3.02e-05	0.000152	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	3.01e-05	0.000152	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CDKN1B—liver cancer	3.01e-05	0.000151	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—AKT1—liver cancer	2.97e-05	0.00015	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GOT2—liver cancer	2.97e-05	0.000149	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	2.96e-05	0.000149	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CASP3—liver cancer	2.95e-05	0.000148	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—IL2—liver cancer	2.94e-05	0.000148	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GOT2—liver cancer	2.94e-05	0.000148	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ALDOB—liver cancer	2.94e-05	0.000148	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—IL6—liver cancer	2.93e-05	0.000147	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—UGDH—liver cancer	2.92e-05	0.000147	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—ALB—liver cancer	2.91e-05	0.000146	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—GSTP1—liver cancer	2.91e-05	0.000146	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GLUL—liver cancer	2.87e-05	0.000144	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CPT1B—liver cancer	2.87e-05	0.000144	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CCND1—liver cancer	2.87e-05	0.000144	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—HMOX1—liver cancer	2.87e-05	0.000144	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—JUN—liver cancer	2.86e-05	0.000144	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GSTA4—liver cancer	2.86e-05	0.000144	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CTNNB1—liver cancer	2.84e-05	0.000143	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PIK3CB—liver cancer	2.81e-05	0.000141	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CRABP1—liver cancer	2.81e-05	0.000141	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.79e-05	0.000141	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CYP2E1—liver cancer	2.79e-05	0.00014	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GSTA2—liver cancer	2.79e-05	0.00014	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MMP9—liver cancer	2.79e-05	0.00014	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PIK3CD—liver cancer	2.78e-05	0.00014	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CDKN1A—liver cancer	2.78e-05	0.00014	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—NR1H4—liver cancer	2.77e-05	0.000139	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CYP2E1—liver cancer	2.77e-05	0.000139	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—EPT1—liver cancer	2.75e-05	0.000138	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—ALB—liver cancer	2.75e-05	0.000138	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	2.73e-05	0.000137	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GSTA3—liver cancer	2.72e-05	0.000137	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MAPK8—liver cancer	2.71e-05	0.000136	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—AKT1—liver cancer	2.7e-05	0.000136	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GSTA1—liver cancer	2.69e-05	0.000135	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—GSTM1—liver cancer	2.67e-05	0.000134	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—H2AFX—liver cancer	2.67e-05	0.000134	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—NAT2—liver cancer	2.66e-05	0.000134	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—RAF1—liver cancer	2.63e-05	0.000132	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	2.62e-05	0.000132	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CYCS—liver cancer	2.61e-05	0.000131	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—TAT—liver cancer	2.6e-05	0.000131	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CYCS—liver cancer	2.59e-05	0.00013	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GOT1—liver cancer	2.56e-05	0.000129	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GGT1—liver cancer	2.56e-05	0.000129	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.56e-05	0.000129	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ALDOB—liver cancer	2.55e-05	0.000128	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GGT1—liver cancer	2.54e-05	0.000128	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GOT1—liver cancer	2.54e-05	0.000128	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—CYP1A1—liver cancer	2.53e-05	0.000127	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	2.51e-05	0.000126	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	2.51e-05	0.000126	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—VEGFA—liver cancer	2.5e-05	0.000126	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GSTA4—liver cancer	2.49e-05	0.000125	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—STAT3—liver cancer	2.48e-05	0.000125	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—HPGDS—liver cancer	2.45e-05	0.000123	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CRABP1—liver cancer	2.43e-05	0.000122	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GSTA2—liver cancer	2.43e-05	0.000122	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PIK3CB—liver cancer	2.42e-05	0.000122	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—PPARA—liver cancer	2.37e-05	0.000119	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—MTHFR—liver cancer	2.36e-05	0.000119	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GSTA1—liver cancer	2.34e-05	0.000118	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	2.34e-05	0.000118	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—MYC—liver cancer	2.32e-05	0.000117	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	2.32e-05	0.000117	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PPARA—liver cancer	2.32e-05	0.000116	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—NAT2—liver cancer	2.32e-05	0.000116	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GSTP1—liver cancer	2.3e-05	0.000116	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MYC—liver cancer	2.3e-05	0.000116	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TGFB1—liver cancer	2.3e-05	0.000115	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GSTP1—liver cancer	2.28e-05	0.000115	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—HMOX1—liver cancer	2.27e-05	0.000114	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—HMOX1—liver cancer	2.25e-05	0.000113	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ALDOB—liver cancer	2.22e-05	0.000112	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—MAPK14—liver cancer	2.19e-05	0.00011	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.19e-05	0.00011	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PSMA4—liver cancer	2.19e-05	0.00011	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PSMD10—liver cancer	2.19e-05	0.00011	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—ESR1—liver cancer	2.15e-05	0.000108	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2.13e-05	0.000107	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GOT2—liver cancer	2.13e-05	0.000107	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—KRAS—liver cancer	2.13e-05	0.000107	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—HPGDS—liver cancer	2.12e-05	0.000107	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CRABP1—liver cancer	2.12e-05	0.000107	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	2.12e-05	0.000106	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GSTM1—liver cancer	2.12e-05	0.000106	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.11e-05	0.000106	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GSTM1—liver cancer	2.1e-05	0.000105	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.08e-05	0.000105	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.06e-05	0.000104	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CYP1A1—liver cancer	2.01e-05	0.000101	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CYP2E1—liver cancer	2e-05	0.000101	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CYP1A1—liver cancer	1.99e-05	0.0001	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PIK3CG—liver cancer	1.98e-05	9.98e-05	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—PPARG—liver cancer	1.96e-05	9.87e-05	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PIK3CA—liver cancer	1.95e-05	9.82e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.92e-05	9.68e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PPARG—liver cancer	1.91e-05	9.63e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.9e-05	9.55e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PSMD10—liver cancer	1.89e-05	9.52e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PSMA4—liver cancer	1.89e-05	9.52e-05	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TP53—liver cancer	1.89e-05	9.5e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CYCS—liver cancer	1.87e-05	9.41e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—MTHFR—liver cancer	1.87e-05	9.4e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—MTHFR—liver cancer	1.85e-05	9.32e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—HPGDS—liver cancer	1.85e-05	9.31e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GOT2—liver cancer	1.84e-05	9.26e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GGT1—liver cancer	1.84e-05	9.23e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GOT1—liver cancer	1.84e-05	9.23e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PPARA—liver cancer	1.83e-05	9.22e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PPARA—liver cancer	1.82e-05	9.14e-05	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—HRAS—liver cancer	1.81e-05	9.09e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CPT1B—liver cancer	1.77e-05	8.9e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GLUL—liver cancer	1.77e-05	8.9e-05	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—SERPINE1—liver cancer	1.77e-05	8.89e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PIK3CD—liver cancer	1.74e-05	8.77e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.74e-05	8.76e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CYP2E1—liver cancer	1.73e-05	8.71e-05	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—IL6—liver cancer	1.73e-05	8.7e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—ALB—liver cancer	1.72e-05	8.66e-05	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PIK3CA—liver cancer	1.71e-05	8.62e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—NR1H4—liver cancer	1.71e-05	8.58e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GSTA3—liver cancer	1.68e-05	8.44e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.68e-05	8.43e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PSMA4—liver cancer	1.65e-05	8.3e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PSMD10—liver cancer	1.65e-05	8.3e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GSTP1—liver cancer	1.65e-05	8.29e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—HMOX1—liver cancer	1.63e-05	8.18e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CYCS—liver cancer	1.62e-05	8.15e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GOT2—liver cancer	1.6e-05	8.07e-05	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—AKT1—liver cancer	1.6e-05	8.03e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GGT1—liver cancer	1.59e-05	8e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GOT1—liver cancer	1.59e-05	8e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.57e-05	7.91e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PIK3CG—liver cancer	1.57e-05	7.9e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PIK3CG—liver cancer	1.56e-05	7.83e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GSTA4—liver cancer	1.53e-05	7.72e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PIK3CB—liver cancer	1.52e-05	7.64e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PPARG—liver cancer	1.52e-05	7.62e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GSTM1—liver cancer	1.52e-05	7.62e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CYP2E1—liver cancer	1.51e-05	7.59e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PPARG—liver cancer	1.5e-05	7.56e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GSTA2—liver cancer	1.5e-05	7.52e-05	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PIK3CA—liver cancer	1.48e-05	7.43e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GSTA1—liver cancer	1.44e-05	7.26e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CYP1A1—liver cancer	1.44e-05	7.23e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GSTP1—liver cancer	1.43e-05	7.18e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—NAT2—liver cancer	1.43e-05	7.17e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.42e-05	7.16e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CYCS—liver cancer	1.41e-05	7.1e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—HMOX1—liver cancer	1.41e-05	7.08e-05	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—AKT1—liver cancer	1.4e-05	7.04e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GGT1—liver cancer	1.39e-05	6.97e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GOT1—liver cancer	1.39e-05	6.97e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PIK3CD—liver cancer	1.38e-05	6.94e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PIK3CD—liver cancer	1.37e-05	6.88e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ALDOB—liver cancer	1.37e-05	6.88e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ALB—liver cancer	1.36e-05	6.85e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ALB—liver cancer	1.35e-05	6.79e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—MTHFR—liver cancer	1.34e-05	6.74e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PPARA—liver cancer	1.31e-05	6.61e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GSTM1—liver cancer	1.31e-05	6.6e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CRABP1—liver cancer	1.3e-05	6.56e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GSTP1—liver cancer	1.24e-05	6.26e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CYP1A1—liver cancer	1.24e-05	6.26e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—HMOX1—liver cancer	1.23e-05	6.17e-05	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—AKT1—liver cancer	1.21e-05	6.07e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PIK3CB—liver cancer	1.2e-05	6.05e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PIK3CB—liver cancer	1.19e-05	6e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—MTHFR—liver cancer	1.16e-05	5.83e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GSTM1—liver cancer	1.14e-05	5.75e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—HPGDS—liver cancer	1.14e-05	5.74e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PPARA—liver cancer	1.14e-05	5.72e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PIK3CG—liver cancer	1.13e-05	5.66e-05	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—MYC—liver cancer	1.12e-05	5.63e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PPARG—liver cancer	1.09e-05	5.46e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CYP1A1—liver cancer	1.08e-05	5.45e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.02e-05	5.14e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PSMD10—liver cancer	1.02e-05	5.11e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PSMA4—liver cancer	1.02e-05	5.11e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—MTHFR—liver cancer	1.01e-05	5.08e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PPARA—liver cancer	9.91e-06	4.99e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PIK3CD—liver cancer	9.89e-06	4.98e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GOT2—liver cancer	9.89e-06	4.97e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ALB—liver cancer	9.77e-06	4.91e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PIK3CG—liver cancer	9.75e-06	4.9e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PPARG—liver cancer	9.41e-06	4.73e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CYP2E1—liver cancer	9.3e-06	4.68e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PIK3CA—liver cancer	9.26e-06	4.66e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CYCS—liver cancer	8.7e-06	4.37e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PIK3CB—liver cancer	8.62e-06	4.34e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PIK3CD—liver cancer	8.57e-06	4.31e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GGT1—liver cancer	8.53e-06	4.29e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GOT1—liver cancer	8.53e-06	4.29e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PIK3CG—liver cancer	8.49e-06	4.27e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ALB—liver cancer	8.46e-06	4.25e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PPARG—liver cancer	8.19e-06	4.12e-05	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—AKT1—liver cancer	7.76e-06	3.9e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GSTP1—liver cancer	7.67e-06	3.86e-05	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—AKT1—liver cancer	7.57e-06	3.81e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—HMOX1—liver cancer	7.56e-06	3.8e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PIK3CB—liver cancer	7.47e-06	3.76e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PIK3CD—liver cancer	7.46e-06	3.75e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ALB—liver cancer	7.37e-06	3.71e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PIK3CA—liver cancer	7.34e-06	3.69e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PIK3CA—liver cancer	7.27e-06	3.66e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GSTM1—liver cancer	7.05e-06	3.54e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CYP1A1—liver cancer	6.68e-06	3.36e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PIK3CB—liver cancer	6.51e-06	3.27e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—MTHFR—liver cancer	6.23e-06	3.13e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PPARA—liver cancer	6.11e-06	3.07e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—AKT1—liver cancer	5.99e-06	3.01e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—AKT1—liver cancer	5.94e-06	2.99e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PIK3CA—liver cancer	5.26e-06	2.64e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PIK3CG—liver cancer	5.23e-06	2.63e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PPARG—liver cancer	5.05e-06	2.54e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PIK3CD—liver cancer	4.6e-06	2.31e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PIK3CA—liver cancer	4.55e-06	2.29e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ALB—liver cancer	4.54e-06	2.28e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—AKT1—liver cancer	4.29e-06	2.16e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PIK3CB—liver cancer	4.01e-06	2.02e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PIK3CA—liver cancer	3.97e-06	1.99e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—AKT1—liver cancer	3.72e-06	1.87e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—AKT1—liver cancer	3.24e-06	1.63e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PIK3CA—liver cancer	2.44e-06	1.23e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—AKT1—liver cancer	2e-06	1e-05	CbGpPWpGaD
